Form 4: RenovoRx CEO Shaun Bagai Increases Stake in Company
SEC Form 4 Filing
RenovoRx CEO Shaun Bagai reports purchasing 10,000 shares of common stock at an average price of $0.83.
Summary
- On April 9, 2025, Shaun Bagai, CEO of RenovoRx, Inc., purchased 10,000 shares of the company's common stock.
- The shares were acquired through open market purchases.
- The average price paid per share was $0.83.
- Following the transaction, Bagai directly owns 312,540 shares of RenovoRx.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive signal, but the document itself is simply a regulatory filing.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's management believes the stock is undervalued.
Stakeholder Impact
- The CEO's increased stake could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/09/2025 | Date of transaction: Shaun Bagai purchased 10,000 shares of RenovoRx common stock. |
| 04/10/2025 | Date of signature on the Form 4 filing. |
Keywords
RenovoRx, RNXT, Shaun Bagai, insider trading, Form 4, stock purchase, CEO, ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.